CLMS 13.77 Calamos Asset Management $CLMS Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board

Nov 3, 2014 at 10:46 PM

CLMS 13.77 Calamos Asset Management $CLMS Hit a 52 week high of 14.44 Closing the day 11/03/14 at 13.77 +0.07 +0.51% With a day low of 13.75 and a total volume of 282,859.

CLMS Recent Posts: http://investorshangout.com/Calamos-Asset-Man...LMS-53704/

CLMS Calamos Asset Management Recent Headline News

Calamos Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO and CHW) Announce Monthly Distributions for November 2014
PR Newswire - Fri Oct 31, 3:01PM CDT
Calamos Investments®* announced today the declaration of monthly distributions on each common share for its five closed-end funds.
CLMS: 13.77 (+0.07)

Calamos Asset Management posts 3Q profit
Automated Insights - Thu Oct 23, 6:19PM CDT
NAPERVILLE, Ill. (AP) _ Calamos Asset Management Inc. (CLMS) on Thursday reported net income of $3.4 million in its third quarter.
CLMS: 13.77 (+0.07)

Calamos Asset Management, Inc. Reports Third Quarter 2014 Results and Declares Dividend
PR Newswire - Thu Oct 23, 3:01PM CDT
Calamos Asset Management, Inc. (NASDAQ: CLMS), representing the public shares outstanding, owns 22.2% of the operating company, Calamos Investments LLC, with the remaining 77.8% privately owned by Calamos Family Partners, Inc. Calamos Asset Management, Inc. (CAM) and Calamos Investments LLC together operate a diversified global investment firm offering equity, fixed income, convertible and alternative strategies, and today reported consolidated results for third quarter 2014 and comparative periods.
CLMS: 13.77 (+0.07), CFGE: 10.31 (+0.13)

Calamos Releases Quarterly Global Economic Review and Outlook October 2014
PR Newswire - Tue Oct 21, 6:00AM CDT
Calamos Investments®*, a globally diversified investment management firm, released its quarterly Global Economic Review and Outlook. The outlook provides the firm's views on the current economic environment and discusses factors that may affect the global markets and investing opportunities and risks. Calamos invites you to read the entire October 2014 Global Economic Review and Outlook at www.calamos.com/outlook.
CLMS: 13.77 (+0.07)

Upgrade Alert for Calamos Asset Management (CLMS)
Comtex SmarTrend(R) - Wed Oct 08, 7:01AM CDT
Calamos Asset Management (NASDAQ:CLMS) was upgraded from Underperform to Market Perform at Keefe Bruyette today. The stock closed yesterday at $11.62 on volume of 144,000 shares, above average daily volume of 94,000. In the past 52 weeks, shares of Calamos Asset Management have traded between a low of $9.46 and a high of $13.90 and closed yesterday at $11.62, which is 23% above that low price. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has declined 0.6%.
CLMS: 13.77 (+0.07)

Calamos Asset Management, Inc. Announces Third Quarter 2014 Investor Conference Call
PR Newswire - Tue Oct 07, 3:01PM CDT
Calamos Asset Management, Inc. (NASDAQ: CLMS) will announce earnings for the third quarter of 2014 after the financial markets close on Thursday, October 23, 2014. An investor conference call is scheduled that day at 3:30 p.m. Central Time.
CLMS: 13.77 (+0.07)

FXA, GOODO, CLMS, SLW, LMAT, CYCCP Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Tue Sep 30, 3:32AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of CurrencyShares Australian Dollar Trust (NYSE:FXA), Gladstone Commercial Corp (NASDAQ:GOODO), Calamos Asset Management Inc (NASDAQ:CLMS), Silver Wheaton Corp (NYSE:SLW), LeMaitre Vascular Inc (NASDAQ:LMAT), Cyclacel Pharmaceuticals Inc (NASDAQ:CYCCP) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
CLMS: 13.77 (+0.07), CYCC: 3.18 (-0.05), FXA: 86.91 (-1.24), LMAT: 7.30 (-0.02), GOOD: 18.17 (+0.07), SLW: 17.91 (+0.54), CYCCP: 7.02 (-0.28), GOODO: 25.45 (-0.07)

Calamos Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO and CHW) Announce Monthly Distributions for October 2014
PR Newswire - Mon Sep 29, 3:01PM CDT
Calamos Investments®* announced today the declaration of monthly distributions on each common share for its five closed-end funds.
CLMS: 13.77 (+0.07)

Calamos Closed-End Funds (NASDAQ: CHI, CHW) Revise Allocation Estimates for September 2014
PR Newswire - Thu Sep 04, 3:01PM CDT
Calamos Investments®* revised its estimates regarding the amounts allocated between ordinary income and return of capital for the September distributions of CHI and CHW. The previously declared September distributions for CHI and CHW remain unchanged.
CLMS: 13.77 (+0.07), CHW: 9.03 (+0.02), CHI: 13.72 (+0.03)

Calamos Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO and CHW) Announce Monthly Distributions for September 2014
PR Newswire - Fri Aug 29, 3:01PM CDT
Calamos Investments®* announced today the declaration of monthly distributions on each common share for its five closed-end funds.
CLMS: 13.77 (+0.07)

GBLI, IBIO, HBOS, CASS, CLMS Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Mon Aug 18, 7:16AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Global Indemnity PLC (NASDAQ:GBLI), Ibio Inc (NYSE:IBIO), Heritage Financial Group Inc (NASDAQ:HBOS), CASS INFORMATION SYSTEMS, INC. (NASDAQ:CASS), Calamos Asset Management Inc (NASDAQ:CLMS) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
CLMS: 13.77 (+0.07), CASS: 45.91 (-1.63), IBIO: 1.08 (+0.05), GBLI: 28.87 (-0.11), HBOS: 21.40 (+0.21)

Calamos Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO and CHW) Announce Monthly Distributions for August 2014
PR Newswire - Fri Aug 01, 3:01PM CDT
Calamos Investments®* announced today the declaration of monthly distributions on each common share for its five closed-end funds.
CLMS: 13.77 (+0.07)

27.5% Return Seen to Date on SmarTrend Calamos Asset Management Call (CLMS)
Comtex SmarTrend(R) - Wed Jul 30, 9:18AM CDT
SmarTrend identified an Uptrend for Calamos Asset Management (NASDAQ:CLMS) on November 22nd, 2013 at $10.71. In approximately 8 months, Calamos Asset Management has returned 27.45% as of today's recent price of $13.65.
CLMS: 13.77 (+0.07)

Calamos Asset Management, Inc. Reports Second Quarter 2014 Results and Increases Dividend By 20 Percent
PR Newswire - Tue Jul 29, 3:01PM CDT
Calamos Asset Management, Inc. (NASDAQ: CLMS), a diversified global investment firm offering equity, fixed income, convertible and alternative strategies, today reported second quarter 2014 results.
CLMS: 13.77 (+0.07), CFGE: 10.31 (+0.13)

Shares of CLMS Up 22.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jul 22, 5:00PM CDT
SmarTrend identified an Uptrend for Calamos Asset Management (NASDAQ:CLMS) on November 22nd, 2013 at $10.71. In approximately 8 months, Calamos Asset Management has returned 22.60% as of today's recent price of $13.13.
CLMS: 13.77 (+0.07)

Calamos Releases Quarterly Global Economic Review and Outlook July 2014
PR Newswire Europe - Mon Jul 21, 1:00AM CDT
Calamos Investments(R)*, a globally diversified investment management firm, released its quarterly Global Economic Review and Outlook. The outlook provides the firm's views on the current economic environment and discusses factors that may affect the global markets and investing opportunities and risks. Calamos invites you to read the entire July 2014 Global Economic Review and Outlook at www.calamos.com/outlook [http://www.calamos.com/Outlook].
CLMS: 13.77 (+0.07)

Calamos Asset Management, Inc. Announces Second Quarter 2014 Investor Conference Call
PR Newswire - Tue Jul 15, 3:01PM CDT
Calamos Asset Management, Inc. (NASDAQ: CLMS) will announce earnings for the second quarter of 2014 after the financial markets close on Tuesday, July 29, 2014. An investor conference call is scheduled that day at 4 p.m. Central Time.
CLMS: 13.77 (+0.07)

Calamos Asset Management Up 23.1% Since SmarTrend Uptrend Call (CLMS)
Comtex SmarTrend(R) - Tue Jul 15, 11:05AM CDT
SmarTrend identified an Uptrend for Calamos Asset Management (NASDAQ:CLMS) on November 22nd, 2013 at $10.71. In approximately 8 months, Calamos Asset Management has returned 23.06% as of today's recent price of $13.18.
CLMS: 13.77 (+0.07)

Calamos Early Leader in Active Equity ETF Space
PR Newswire - Mon Jul 14, 7:30AM CDT
Calamos Investments announces the launch of the Calamos Focus Growth ETF (NASDAQ: CFGE), one of the industry's first actively managed equity ETFs.
CLMS: 13.77 (+0.07), CFGE: 10.31 (+0.13)

Calamos Asset Management (CLMS) Stock Research Links

CLMS Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CapCut's AI Tools Reshape Video Content Creation

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Aluminum Design Fumble: Geometry Over Wall Thickness

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Darden Faces Class Action Over Reimbursement Failures

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...